Skip to content

SRNE SORRENTO THERAPEUTICS, INC.

Follow

COMMON STOCK (common)

5 managers (5 13F filers) reported a position in SRNE shares at 2025-03-31, 6,089 shares in all. 1 filer opened a position and 3 filers sold out during the quarter.

Managers
5
13F filers
5
New
1
Added
1
Reduced
0
Sold out
3
Shares held by filers
6,089

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q1 2025

Filers in the available 13F reports with a share position at 2025-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
HUNTINGTON NATIONAL BANKin group HUNTINGTON NATIONAL BANK5,001$4<0.01%013F-HRTimelineGroup
FLAGSHIP WEALTH ADVISORS, LLC1,000$00%+50013F-HR/ATimelineValue filed as zero, left out of ratios.
Vermillion Wealth Management, Inc.70$00%new13F-HRTimelineValue filed as zero, left out of ratios.
Financial Gravity Asset Management, Inc.in group Financial Gravity Companies, …18$00%13F-HRTimelineGroupValue filed as zero, left out of ratios.
CONCOURSE FINANCIAL GROUP SECURITIES, I…0$0013F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios.